MARKET

CBLI

CBLI

Cleveland Biolbs
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.170
-0.080
-3.56%
Closed 16:00 07/10 EDT
OPEN
2.140
PREV CLOSE
2.250
HIGH
2.240
LOW
2.100
VOLUME
236.17K
TURNOVER
--
52 WEEK HIGH
5.00
52 WEEK LOW
0.5000
MARKET CAP
28.03M
P/E (TTM)
-10.3877
1D
5D
1M
3M
1Y
5Y

EPS

CBLI News

More
ICPT, WKHS, HRTX and BLNK among midday movers
Seeking Alpha - Article · 06/29 16:41
Cleveland BioLabs joins COVID vaccine-stoked rally
Seeking Alpha - Article · 06/26 19:28
GPS, LK, IBIO and MMLP among midday movers
Seeking Alpha - Article · 06/26 16:42
71 Biggest Movers From Yesterday
Gainers Cemtrex, Inc. (NASDAQ: CETX) shares climbed 172.4% to close at $2.58 on Monday following earlier press release highlighting release of new thermal body temperature measurement camera, the V1100B-THM-TEMP.
Benzinga · 06/02 08:39
MYOV, NBRV, RWLK and WWR among midday movers
Seeking Alpha - Article · 06/01 16:43
48 Stocks Moving In Monday's Mid-Day Session
Gainers Cemtrex, Inc. (NASDAQ: CETX) shares jumped 198% to $2.8199.
Benzinga · 06/01 16:34
Cleveland Biolabs -11.7% on $3.175M registered direct offering
Seeking Alpha - Article · 06/01 14:17
Cleveland BioLabs S-3 Shows Registration For $50M Mixed Securities Shelf
Benzinga · 05/21 21:14

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About CBLI

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. Its other products include CBLB612, Mobilan and CBL0137. CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. CBL0137 is a small molecule with a multi-targeted mechanism of action that may be useful for the treatment of various types of cancer.
More

Webull offers kinds of Cleveland BioLabs, Inc. stock information, including NASDAQ:CBLI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CBLI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CBLI stock methods without spending real money on the virtual paper trading platform.